The Clinic That Replaced Waiting Lists - A Child's Dangerous Dose
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Clinic That Replaced Waiting Lists - A Child's Dangerous Dose
-
ナレーター：
-
著者：
概要
Fear that a system built to save children instead exposed them to life‑threatening risk: a child with no prior testosterone exposure was put on the highest possible starting dose within days, and by May 2024 a consultant paediatric endocrinologist warned in court the child was "presently at risk of sudden death due to thromboembolic disease." How did a telemedicine clinic meant to bypass NHS waiting lists reach that point?
In this episode, we lay out the sequence of events that took a clinic from promise to scandal, describing the clinic's founding, its clinical practices, the regulatory responses and the undercover reporting that provoked public alarm - and we ask whether replacing one failing system created another riskier one.
Person: Helen Webberley
Person: Mike Webberley
Event: The Telegraph undercover investigation, February 2021
Date: May 2024 (High Court testimony)
Location: London
- A child with no prior testosterone exposure was prescribed the highest possible starting dose within days.
- By May 2024 a consultant paediatric endocrinologist told a High Court judge the child was "presently at risk of sudden death due to thromboembolic disease."
- GenderGP was founded in 2015 by GP Helen Webberley and operated as an online-only telemedicine clinic using the principle "stage not age."
- In May 2017 the General Medical Council placed Helen Webberley under interim suspension after complaints from NHS clinicians.
- In February 2021 The Telegraph's undercover reporters obtained consultations where testosterone was offered to a reporter posing as a 15-year-old and blockers discussed for a 12-year-old who was not present.
To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.
© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません